and hepatotoxins. [5][6][7] The drug was also found to decrease We used an animal model of extrahepatic biliary obstrucfibrogenesis in a model of experimental cirrhosis produced tion of 7 days' duration to study the production of thiobarbiby CCl 4 administration. 8 From an experimental standpoint, turic acid reactive substances (TBARS), total glutathione extrahepatic biliary obstruction caused by bile duct ligature (TG), reduced glutathione (GSH), and oxidized glutathione reliably reproduces the cholestasis syndrome, 9-11 and thus (GSSG), and the enzymatic activities of GSH-peroxidase, provides an optimal model for the study of hepatoprotective GSSG-reductase, and GSH-transferase. Four groups of six rats drugs. We used this model to investigate the hepatoprotective each were treated with saline, drug solvent, S-adenosyl-L-meeffects of SAM 12 with biochemical and histopathological analthionine (SAM) 5 mg/kg/d, subcutaneously, or SAM 10 mg/kg/ yses. The present study was designed to evaluate the protecd, subcutaneously. Extrahepatic biliary obstruction increased tive effect of two doses of SAM in a model of acute cholestasis.
TBARS. SAM had the dose-dependent effects of inhibitingWe measured biochemical parameters and oxidative stress, TBARS production and increasing TG content, mainly as a which was estimated as the equilibrium between oxidating result of the increase in GSH. The activity of GSH-peroxidase factors (thiobarbituric acid reactive substances and oxidized and GSH-transferase was also significantly increased. In renal glutathione [GSSG]) and antioxidant defenses (levels of retissue these effects were statistically significant only in aniduced glutathione and activity of enzymes that control glutamals given the higher dose of SAM. In liver we found a reducthione). Through transmethylation reactions, SAM restores plasma duct. For surgery the animals were anesthetized with ethyl ether membrane fluidity in hepatocytes 3 ; transsulfuration reac-and an abdominal midline incision was made. Muscle and peritoneal tions enhance the detoxicant capacity of hepatocytes by structures were dissected to expose the bile duct, which was careincreasing the amount of endogenous cysteine, glutathione, fully dissected and ligated with braided silk at two levels.13 Surgery and taurine. 2,4 in the sham-operated group was performed with the same procedure except that the bile duct was not ligated.
Recent clinical and experimental studies have shown thatEach of these two groups was divided into four treatment groups treatment with SAM has important benefits in intrahepatic (n Å 6 rats per group): 1) isotonic saline solution (pH 7.4), 2) SAM cholestasis caused by liver disease associated with acute or solvent (L-lysine, pH 7.4), 3) SAM 5 mg/kg/d (Boehringer Ingelheim chronic cholestasis, pregnancy, and the use of certain drugs Españ a SA, Barcelona, Spain), and 4) SAM 10 mg/kg/d. In groups 1 and 2 we administered a volume equivalent to that used for the higher dose of SAM. In all, 48 animals were used.In all groups the route of ...